The DOI matches its Crossref record.
Silver Products for Medical Indications: Risk-Benefit Assessment
Abstract
BACKGROUND: Legitimate medicinal use of silver-containing products has dramatically diminished over the last several decades. Recently, however, some manufacturers have begun to enthusiastically promote oral colloidal silver proteins as mineral supplements and for prevention and treatment of many diseases. Indiscriminate use of silver products can lead to toxicity such as argyria. OBJECTIVE: To assist health care professionals in a risk versus benefit assessment of over-the-counter silver-containing products, we herein examine the following issues: historical uses, chemistry, pharmacology, clinical toxicology, case reports of adverse events in the literature, and the recent promotion of over-the-counter silver products. Other sources of silver exposure (including environmental and dietary) and EPA exposure standards are discussed. A list of currently available silver products is provided for easy reference and screening. CONCLUSIONS: We emphasize the lack of established effectiveness and potential toxicity of these products.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Silver as Antibacterial Agent: Ion, Nanoparticle, and Metal
Chernousova, S., & Epple, M. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201205923 · Cited by 2,264
Bacterial silver resistance: molecular biology and uses and misuses of silver compounds
Silver, S. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00047-0 · Cited by 1,312
Reidy, B., Haase, A., Luch, A., Dawson, K., & Lynch, I. (2013) · Materials · doi:10.3390/ma6062295 · Cited by 1,035
120 Years of Nanosilver History: Implications for Policy Makers
Nowack, B., Krug, H. F., & Height, M. (2011) · Environmental Science & Technology · doi:10.1021/es103316q · Cited by 829
Exposure-Related Health Effects of Silver and Silver Compounds: A Review
(2005) · The Annals of Occupational Hygiene · doi:10.1093/annhyg/mei019 · Cited by 727
Metadata
- Authors
- Fung, M. C., & Bowen, D. L.
- Venue
- Journal of Toxicology: Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 1996-01
- Volume
- 34
- Issue
- 1
- Pages
- 119-126
- ISSN
- 0731-3810 (ISSN-L)
- OpenAlex
- W2134915807
- Cited by
- 250
- References
- 0
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Silver Products for Medical Indications: Risk-Benefit Assessment. https://app.cochat.ai/papers/10.3109/15563659609020246
- The paper
- Fung, M. C., & Bowen, D. L. (1996). Silver Products for Medical Indications: Risk-Benefit Assessment. Journal of Toxicology: Clinical Toxicology. https://doi.org/10.3109/15563659609020246
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.